121.Biswas S, Munier FL, Yardley J, et al: Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet 2001; 10:2415-2423.
122.Laule A, Cable MK, Hoffman CE, et al: Endothelial cell population changes of human cornea during life. Arch Ophthalmol 1978; 96:2031-2035.
123.Thoft RA, Friend J: The X, Y, Z, hypothesis of corneal epithelial maintenance. Invest Ophthalmol Vis Sci 1983; 24:1442-1443.
124.Cotsareils G, Cheng S-Z, Dong G, et al: Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell 1989; 57:201-209.
125.Daniels JT, Harris AR, Mason C: Corneal epithelial stem cells in health and disease. Stem Cell Rev 2006; 2:247-254.
126.O'Sullivan F, Clynes M: Limbal stem cells, a review of their identification and culture for clinical use. Cytotechnology 2007; 53:101-106.
127.Secker GA, Daniels JT: Corneal epithelial stem cells: deficiency and regulation. Stem Cell Rev 2008; 4:159-168.
128.Binder PS, Wickham MG, Zavala EY, et al: Corneal anatomy and wound healing. In: Barraque JI, Binder PS, Buxton JN, et al ed. Symposium on medical and surgical diseases of the cornea, St. Louis, MO: Mosby; 1980:1-35.
129.Kuwabara T, Perkins DG, Cogan DG: Sliding of the epithelium in experimental corneal wounds. Invest Ophthalmol Vis Sci 1976; 15:4-14.
130.Buck RC: Cell migration in repair of mouse corneal epithelium. Invest Ophthalmol Vis Sci 1979; 18:767-784.
131.Hanna C: Proliferation and migration of epithelial cells. Am J Ophthalmol 1966; 61:55-63.
132.Matsuda H, Smelser GK: Electron microscopy of corneal wound healing. Exp Eye Res 1973; 16:427-442.
133.Proctor RA: Fibronectin: a brief overview of its structure, function, and physiology. Rev Infect Dis 1987; 9(suppl 4):S317-S321.
134.Cameron JD, Hagen ST, Waterfield RR, et al: Effects of matrix proteins on rabbit corneal epithelial cell adhesion and migration. Curr Eye Res 1988; 7:293-301.
135.Nakagawa S, Nishida T, Kodama Y, et al: Spreading of cultured corneal epithelial cells on fibronectin and other extracellular matrices. Cornea 1990; 9:125-130.
136.Stepp MA, Spurr-Michaud S, Gipson IK: Integrins in the wounded and unwounded stratified squamous epithelium of the cornea. Invest Ophthalmol Vis Sci 1993; 34:1829-1844.
137.Latvala T, Tervo K, Tervo T: Reassembly of the α6β4 integrin and laminin in rabbit corneal basement membrane after excimer laser surgery: a 12-month follow-up. CLAO J 1995; 21:125-129.
138.Itano N: Simple primary structure, complex turnover regulation and multiple roles of hyaluronan. J Biochem 2008; 144:131-137.
139.Fitzsimmons TD, Fagerholm P, Harfstrand A, et al: Hyaluronic acid in the rabbit cornea after excimer laser superficial keratectomy. Invest Ophthalmol Vis Sci 1992; 33:3011-3016.
140.Fagerholm P, Fitzsimmons T, Harfstrand A, et al: Reactive formation of hyaluronic acid in the rabbit corneal alkali burn. Acta Ophthalmol Suppl (Copenh) 1992; 202:67-72.
141.Nakamura M, Hikida M, Nakano T: Concentration and molecular weight dependency of rabbit corneal epithelial wound healing on hyaluronan. Curr Eye Res 1992; 11:981-986.
142.Nakamura M, Sato N, Chikama TI, et al: Hyaluronan facilitates corneal epithelial wound healing in diabetic rats. Exp Eye Res 1997; 64:1043-1050.
143.Nakamura M, Nishida T: Recent developments in the use of hyaluronan in wound healing. Exp Opin Invest Drugs 1995; 4:175-188.
144.Nishida T, Nakamura M, Mishima H, et al: Hyaluronan stimulates corneal epithelial migration. Exp Eye Res 1991; 53:753-758.
145.Salonen E-M, Tervo T, Torma E, et al: Plasmin in tear fluid of patients with corneal ulcers: basis for new therapy. Acta Ophthalmol 1987; 65:3-12.
146.Hayashi K, Sueishi K: Fibrinolytic activity and species of plasminogen activator in human tears. Exp Eye Res 1988; 46:131-137.
147.Sivak JM, Fini ME: MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002; 21:1-14.
148.Barrientos S, Stojadinovic O, Golinko MS, et al: Growth factors and cytokines in wound healing. Wound Repair Regen 2008; 16:585-601.
149.Cohen S: Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 1962; 237:1555-1562.
150.Frati L, Daniele S, Delogu A, et al: Selective binding of the epidermal growth factor and its specific effects on the epithelial cells of the cornea. Exp Eye Res 1972; 14:135-141.
151.Savage CRJ, Cohen S: Proliferation of corneal epithelium induced by epidermal growth factor. Exp Eye Res 1973; 15:361-366.
152.Ho PC, Davis WH, Elliott JH, et al: Kinetics of corneal epithelial regeneration and epidermal growth factor. Invest Ophthalmol Vis Sci 1974; 13:804-809.
153.Gonul B, Koz M, Ersoz G, et al: Effect of EGF on the corneal wound healing of alloxan diabetic mice. Exp Eye Res 1992; 54:519-524.
154.Nishida T, Nakamura M, Murakami J, et al: Epidermal growth factor stimulates corneal epithelial cell attachment to fibronectin through a fibronectin receptor system. Invest Ophthalmol Vis Sci 1992; 33:2464-2469.
155.Nishida T, Nakamura M, Mishima H, et al: Differential modes of action of fibronectin and epidermal growth factor on rabbit corneal epithelial migration. J Cell Physiol 1990; 145:549-554.
156.Wilson SE, Lloyd SA, He YG: EGF, basic FGF, and TGFβ-1 messenger RNA production in rabbit corneal epithelial cells. Invest Ophthalmol Vis Sci 1992; 33:1987-1995.
157.Roberts AB, Russo A, Felici A, et al: Smad3: a key player in pathogenetic mechanisms dependent on TGF-β. Ann NY Acad Sci 2003; 995:1-10.
158.Mishima H, Nakamura M, Murakami J, et al: Transforming growth factor-β modulates effects of epidermal growth factor on corneal epithelial cells. Curr Eye Res 1992; 11:691-696.
159.Steiling H, Werner S: Fibroblast growth factors: key players in epithelial morphogenesis, repair and cytoprotection. Curr Opin Biotechnol 2003; 14:533-537.
160.Rieck P, Assouline M, Savoldelli M, et al: Recombinant human basic fibroblast growth factor (Rh-bFGF) in three different wound models in rabbits: corneal wound healing effect and pharmacology. Exp Eye Res 1992; 54:987-998.
161.Knorr M, Steuhl K, Tatje D, et al: A rabbit corneal epithelial cell line expresses functional platelet-derived growth factor β-type receptors. Invest Ophthalmol Vis Sci 1992; 33:2207-2211.
162.Steinke JW, Borish L: 3. Cytokines and chemokines. J Allergy Clin Immunol 2006; 117:S441-S445.
163.Wilson SE, Liu JJ, Mohan RR: Stromal-epithelial interactions in the cornea. Prog Retin Eye Res 1999; 18:293-309.
164.Sakamoto S, Inada K, Chiba K, et al: Production of IL-6 and IL-1a by human corneal epithelial cells. Acta Soc Ophthalmol Jpn 1991; 95:728-732.
165.Nishida T, Nakamura M, Mishima H, et al: Interleukin 6 facilitates corneal epithelial wound closure in vivo. Arch Ophthalmol 1992; 110:1292-1294.
166.Ohashi H, Maeda T, Mishima H, et al: Up-regulation of integrin α5β1 expression by interleukin-6 in rabbit corneal epithelial cells. Exp Cell Res 1995; 218:418-423.
167.Bisla K, Tanelian DL: Concentration-dependent effects of lidocaine on corneal epithelial wound healing. Invest Ophthalmol Vis Sci 1992; 33:3029-3033.
168.Pernow B, Substance P: Pharmacol Rev 1983; 35:85-141.
169.McGillis JP, Organist ML, Payan DG: Substance P and immunoregulation. Fed Proc 1987; 46:196-199.
170.Payan DG: Neuropeptides and inflammation: the role of substance P. Annu Rev Med 1989; 40:341-352.
171.Wallengren J, Hakanson R: Effects of substance P, neurokinin A and calcitonin gene-related peptide in human skin and their involvement in sensory nerve-mediated responeses. Eur J Pharmacol 1987; 143:267-273.
172.Shimizu Y: Localization of neuropeptides in the cornea and uvea of the rat: an immunohistochemical study. Cell Mol Biol 1982; 28:103-110.
173.Nishiyama A, Masuda K, Mochizuki M: Ocular effects of substance P. Jpn J Ophthalmol 1981; 25:362-369.
174.Cook GA, Elliott D, Metwali A, et al: Molecular evidence that granuloma T lymphocytes in murine Schistosomiasis mansoni express an authentic substance P (NK-1) receptor. J Immunol 1994; 152:1830-1835.
175.Kaplan JE: Plasma fibronectin and resistance to thrombosis during sepsis. Adv Shock Res 1982; 7:159-172.
176.Brown SM, Lamberts DW, Reid TW, et al: Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1. Arch Ophthalmol 1997; 115:926-927.
177.Chikama T, Fukuda K, Morishige N, et al: Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I. Lancet 1998; 351:1783-1784.
178.Morishige N, Komatsubara T, Chikama T, et al: Direct observation of corneal nerve fibres in neurotrophic keratopathy by confocal biomicroscopy. Lancet 1999; 354:1613-1614.
179.Levi-Montalcini R: The nerve growth factor 35 years later. Science 1987; 237:1154-1162.
180.Rask CA: Biological actions of nerve growth factor in the peripheral nervous system. Eur Neurol 1999; 41(suppl 1):14-19.
181.Levi-Montalcini R, Hamburger V: A diffusible agent of mouse sarcoma producing hyperplasia of sympathic ganglia and hyperneurotization of the chick embryo. J Exp Zool 1953; 123:233-388.